Follow-up ultrasound may be enough for thyroid nodules from 5 mm to 1 cm in size

Soo Yeon Kim, Hye Sun Lee, Eunkyung Kim, Hee Jung Moon, Jung Hyun Yoon, Jung Hwa Hong, jinyoung kwak

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We investigated whether follow-up ultrasound (US) is enough for thyroid nodules 5–10 mm, and whether 3 years of interval between the initial US and next US is appropriate. This retrospective study was approved by the Institutional Review Board, and the need to obtain informed consent was waived. The study included 447 thyroid nodules 5–10 mm from 378 patients who underwent initial thyroid US, and underwent 3 years or more of follow-up US. The presence and characteristics of malignancy detected on follow-up were reviewed. Maximal diameters of each nodule at the initial and last US were measured. Univariate and multivariate analysis were used to assess association with nodule growth 3 mm or larger. Seven malignancies (1.6 %, 7 of 447) were detected on a mean 70.6 ± 20.3 months (range 36–104 months). Only one had growth 3 mm or larger, and all malignancies did not have extensive extrathyroidal extension, lateral lymph nodes, or distant metastasis. 6.0 % (27 of 447) of nodules had growth 3 mm or larger. Nodules in older patients were less likely to grow, and benign-looking nodules were more likely to grow. Longer follow-up time 6 years or more was not associated with growth, and no cancers were detected during the long follow-up time. Immediate US-FNA for thyroid nodules 5–10 mm are discouraged, unless suspicious metastatic lymph nodes are present. Also, a follow-up US 3 years after the initial US may be enough for these nodules.

Original languageEnglish
Pages (from-to)130-138
Number of pages9
JournalEndocrine
Volume52
Issue number1
DOIs
Publication statusPublished - 2016 Apr 1

Fingerprint

Thyroid Nodule
Growth
Neoplasms
Lymph Nodes
Research Ethics Committees
Informed Consent
Thyroid Gland
Multivariate Analysis
Retrospective Studies
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Kim, Soo Yeon ; Lee, Hye Sun ; Kim, Eunkyung ; Moon, Hee Jung ; Yoon, Jung Hyun ; Hong, Jung Hwa ; kwak, jinyoung. / Follow-up ultrasound may be enough for thyroid nodules from 5 mm to 1 cm in size. In: Endocrine. 2016 ; Vol. 52, No. 1. pp. 130-138.
@article{106af2c888094defa9f59a74b262fb74,
title = "Follow-up ultrasound may be enough for thyroid nodules from 5 mm to 1 cm in size",
abstract = "We investigated whether follow-up ultrasound (US) is enough for thyroid nodules 5–10 mm, and whether 3 years of interval between the initial US and next US is appropriate. This retrospective study was approved by the Institutional Review Board, and the need to obtain informed consent was waived. The study included 447 thyroid nodules 5–10 mm from 378 patients who underwent initial thyroid US, and underwent 3 years or more of follow-up US. The presence and characteristics of malignancy detected on follow-up were reviewed. Maximal diameters of each nodule at the initial and last US were measured. Univariate and multivariate analysis were used to assess association with nodule growth 3 mm or larger. Seven malignancies (1.6 {\%}, 7 of 447) were detected on a mean 70.6 ± 20.3 months (range 36–104 months). Only one had growth 3 mm or larger, and all malignancies did not have extensive extrathyroidal extension, lateral lymph nodes, or distant metastasis. 6.0 {\%} (27 of 447) of nodules had growth 3 mm or larger. Nodules in older patients were less likely to grow, and benign-looking nodules were more likely to grow. Longer follow-up time 6 years or more was not associated with growth, and no cancers were detected during the long follow-up time. Immediate US-FNA for thyroid nodules 5–10 mm are discouraged, unless suspicious metastatic lymph nodes are present. Also, a follow-up US 3 years after the initial US may be enough for these nodules.",
author = "Kim, {Soo Yeon} and Lee, {Hye Sun} and Eunkyung Kim and Moon, {Hee Jung} and Yoon, {Jung Hyun} and Hong, {Jung Hwa} and jinyoung kwak",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s12020-015-0740-5",
language = "English",
volume = "52",
pages = "130--138",
journal = "Endocrine",
issn = "0969-711X",
publisher = "Humana Press",
number = "1",

}

Follow-up ultrasound may be enough for thyroid nodules from 5 mm to 1 cm in size. / Kim, Soo Yeon; Lee, Hye Sun; Kim, Eunkyung; Moon, Hee Jung; Yoon, Jung Hyun; Hong, Jung Hwa; kwak, jinyoung.

In: Endocrine, Vol. 52, No. 1, 01.04.2016, p. 130-138.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Follow-up ultrasound may be enough for thyroid nodules from 5 mm to 1 cm in size

AU - Kim, Soo Yeon

AU - Lee, Hye Sun

AU - Kim, Eunkyung

AU - Moon, Hee Jung

AU - Yoon, Jung Hyun

AU - Hong, Jung Hwa

AU - kwak, jinyoung

PY - 2016/4/1

Y1 - 2016/4/1

N2 - We investigated whether follow-up ultrasound (US) is enough for thyroid nodules 5–10 mm, and whether 3 years of interval between the initial US and next US is appropriate. This retrospective study was approved by the Institutional Review Board, and the need to obtain informed consent was waived. The study included 447 thyroid nodules 5–10 mm from 378 patients who underwent initial thyroid US, and underwent 3 years or more of follow-up US. The presence and characteristics of malignancy detected on follow-up were reviewed. Maximal diameters of each nodule at the initial and last US were measured. Univariate and multivariate analysis were used to assess association with nodule growth 3 mm or larger. Seven malignancies (1.6 %, 7 of 447) were detected on a mean 70.6 ± 20.3 months (range 36–104 months). Only one had growth 3 mm or larger, and all malignancies did not have extensive extrathyroidal extension, lateral lymph nodes, or distant metastasis. 6.0 % (27 of 447) of nodules had growth 3 mm or larger. Nodules in older patients were less likely to grow, and benign-looking nodules were more likely to grow. Longer follow-up time 6 years or more was not associated with growth, and no cancers were detected during the long follow-up time. Immediate US-FNA for thyroid nodules 5–10 mm are discouraged, unless suspicious metastatic lymph nodes are present. Also, a follow-up US 3 years after the initial US may be enough for these nodules.

AB - We investigated whether follow-up ultrasound (US) is enough for thyroid nodules 5–10 mm, and whether 3 years of interval between the initial US and next US is appropriate. This retrospective study was approved by the Institutional Review Board, and the need to obtain informed consent was waived. The study included 447 thyroid nodules 5–10 mm from 378 patients who underwent initial thyroid US, and underwent 3 years or more of follow-up US. The presence and characteristics of malignancy detected on follow-up were reviewed. Maximal diameters of each nodule at the initial and last US were measured. Univariate and multivariate analysis were used to assess association with nodule growth 3 mm or larger. Seven malignancies (1.6 %, 7 of 447) were detected on a mean 70.6 ± 20.3 months (range 36–104 months). Only one had growth 3 mm or larger, and all malignancies did not have extensive extrathyroidal extension, lateral lymph nodes, or distant metastasis. 6.0 % (27 of 447) of nodules had growth 3 mm or larger. Nodules in older patients were less likely to grow, and benign-looking nodules were more likely to grow. Longer follow-up time 6 years or more was not associated with growth, and no cancers were detected during the long follow-up time. Immediate US-FNA for thyroid nodules 5–10 mm are discouraged, unless suspicious metastatic lymph nodes are present. Also, a follow-up US 3 years after the initial US may be enough for these nodules.

UR - http://www.scopus.com/inward/record.url?scp=84944711418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944711418&partnerID=8YFLogxK

U2 - 10.1007/s12020-015-0740-5

DO - 10.1007/s12020-015-0740-5

M3 - Article

C2 - 26394881

AN - SCOPUS:84944711418

VL - 52

SP - 130

EP - 138

JO - Endocrine

JF - Endocrine

SN - 0969-711X

IS - 1

ER -